Postoperative Inflammation of the Eye

• FDA approval · 2013-12-16
  FDA Approved: LOTEPREDNOL ETABONATE — Supplemental Application (Bausch & Lomb Americas Inc.)

  The FDA approved a supplemental application for Loteprednol Etabonate (Lotemax) from Bausch & Lomb Americas Inc.

• FDA label_change · 2013-05-15
  FDA Approved: DIFLUPREDNATE OPHTHALMIC — Supplemental Application (Sandoz Inc)

  The FDA approved a supplemental application for difluprednate ophthalmic from Sandoz, updating labeling (new indication or labeling changes)…

• FDA approval · 2011-04-15
  FDA Approved: LOTEMAX — Original Application (Bausch & Lomb Incorporated)

  FDA approved Lotemax (loteprednol etabonate) under Original Application (NDA200738) for ophthalmic use to treat inflammatory conditions of t…

• FDA approval · 2009-03-20
  FDA Approved: DIFLUPREDNATE OPHTHALMIC — Supplemental Application (Sandoz Inc)

  FDA approved Sandoz Inc's supplemental application for difluprednate ophthalmic, approving a generic corticosteroid ophthalmic solution for …